Loading
A phase 2 trial in colorectal cancer, run by Guangzhou University of Traditional Chinese Medicine, not yet recruiting.
Study of Fruquintinib Combined With Tegafur Gimeracil Oteracil in Patients With Metastatic Colorectal Cancer is a phase 2, interventional study registered as NCT06255379 by Guangzhou University of Traditional Chinese Medicine, with a registry enrolment figure of 52 participants, started 2024-05-06 and due to reach its primary completion in 2027-03-21. Interventions recorded: Fuquinitinib+Tegafur Gimeracil Oteracil. Conditions listed: Metastasis Colorectal Cancer; Colon Cancer; Rectal Cancer. Primary outcome: Progression Free Survival (PFS). Colorectal eligibility wording from the registry: "Histologically and/or cytologically documented metastatic colorectal adenocarcinoma;". Sites: China. No results are recorded here; the registry entry is the source.
Shares Colon cancer (adenocarcinoma of the colon), Colorectal cancer trials open today (registry snapshot), Rectal cancer and the tag colorectal-deep-dive.
Shares Colon cancer (adenocarcinoma of the colon), Colorectal cancer trials open today (registry snapshot), Rectal cancer and the tag colorectal-deep-dive.
Shares Colon cancer (adenocarcinoma of the colon), Colorectal cancer trials open today (registry snapshot), Rectal cancer and the tag colorectal-deep-dive.
Shares Colon cancer (adenocarcinoma of the colon), Colorectal cancer trials open today (registry snapshot), Rectal cancer and the tag colorectal-deep-dive.
Shares Colon cancer (adenocarcinoma of the colon), Colorectal cancer trials open today (registry snapshot), Rectal cancer and the tag colorectal-deep-dive.
Shares Colon cancer (adenocarcinoma of the colon), Colorectal cancer trials open today (registry snapshot), Rectal cancer and the tag colorectal-deep-dive.
Shares Colon cancer (adenocarcinoma of the colon), Colorectal cancer trials open today (registry snapshot), Rectal cancer and the tag colorectal-deep-dive.
Shares Colon cancer (adenocarcinoma of the colon), Colorectal cancer trials open today (registry snapshot), Rectal cancer and the tag colorectal-deep-dive.